Irritable Bowel Syndrome (IBS) Completed Phase 2 Trials for Ramosetron (DB09290)

Also known as: Irritable Bowel Disease / IBS (Irritable Bowel Syndrome) / IBS / IBS - Irritable Bowel Syndrome / Irritable Bowel / Colitis, Mucous / Irritable Colon / Colon, Irritable / Irritable Bowel Syndrome(IBS) / Irritable Bowel Syndrome / Mucous colitis / Colitis mucous / Irritable bowel syndrome NOS / Colon spastic / Spastic colon / Irritable colon syndrome / [X]Psychogenic IBS / Functional bowel syndrome

IndicationStatusPhase
DBCOND0030069 (Irritable Bowel Syndrome (IBS))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00189813A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)Treatment
NCT01274000A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female PatientsTreatment